Yumanity Therapeutics

Yumanity Therapeutics

Biotechnology company that transforms drug discovery for diseases caused by protein misfolding.

HQ location
Cambridge, United States
Website
yumanity.com
Launch date
Employees
2-10 people
Market cap
$20.5m
Enterprise value
$12m
Share price
$1.89 YMTX
Recent deals
https://twitter.com/yumanitytxhttps://www.linkedin.com/company/yumanity-therapeutics/
    • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor investor

€0.0

round
*

N/A

Acquisition
Total Funding000k
Dolby Family Ventures
Dolby Family Ventures(exited)
Altium Capital Management
Altium Capital Management(exited)
Kineta
Kineta
Fidelity Investments
Fidelity Investments(exited)
Invus
Invus(exited)

Related Content

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Yumanity Therapeutics

Edit
Proteostasis Therapeutics
Proteostasis Therapeutics
ACQUISITION by Yumanity Therapeutics Dec 2020